13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 56 holding rows worth $749,540,798.
- Accession
- 0001172661-23-003853
- Filer
- CIK 1792126
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 56 entries on the cover page, a total value of $749,540,798 stated on the cover page (in dollars after the unit check, H1), rows summing to $749,540,798 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IMMUNOVANT INC | 45258J102 | COM | 1,600,000 | $61,424,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,250,000 | $60,705,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,743,875 | $46,236,856 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,975,000 | $40,467,750 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,250,000 | $36,825,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 600,000 | $30,348,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 750,000 | $28,530,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 500,000 | $25,210,000 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 650,000 | $24,726,000 | dollars as filed | call |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 200,000 | $24,244,000 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 450,000 | $23,355,000 | dollars as filed | |
| ICOSAVAX INC | 45114M109 | COM | 2,765,741 | $21,434,493 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,180,000 | $19,532,800 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 115,000 | $19,445,350 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 150,000 | $16,875,000 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,050,000 | $16,107,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 450,000 | $15,372,000 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 700,000 | $15,281,000 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,200,000 | $14,016,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 500,000 | $13,185,000 | dollars as filed | call |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 300,000 | $13,068,000 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 5,300,000 | $12,508,000 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,050,000 | $12,159,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 5,032,501 | $11,876,702 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 4,650,000 | $10,555,500 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 400,000 | $10,548,000 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 400,000 | $9,170,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 900,000 | $8,667,000 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 225,000 | $7,814,250 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 250,000 | $7,435,000 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 2,525,000 | $7,272,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 950,000 | $7,030,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 250,000 | $6,920,000 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 950,000 | $6,384,000 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 500,000 | $6,040,000 | dollars as filed | call |
| GERON CORP | 374163103 | COM | 2,750,000 | $5,830,000 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 245,000 | $5,777,100 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,000,000 | $4,800,000 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 310,000 | $4,786,400 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 1,000,000 | $4,550,000 | dollars as filed | call |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 1,044,444 | $4,229,998 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 307,076 | $4,194,658 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 544,960 | $4,065,402 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 125,000 | $3,688,750 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 300,000 | $3,624,000 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 215,000 | $2,850,900 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 424,000 | $2,798,400 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 210,000 | $2,572,500 | dollars as filed | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 115,000 | $1,322,500 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 188,390 | $1,015,422 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 493,827 | $696,296 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 421,184 | $619,140 | dollars as filed | |
| CYPHERPUNK TECHNOLOGIES INC | 52187K200 | COM NEW | 354,266 | $488,887 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 31,872 | $438,877 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 280,000 | $417,200 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $6,667 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-23-003853 | this filing | 2023-11-14 | acceptance time not in the bulk data set |